000513SZSE

Announcement of Resolutions from the 2025 Annual General Meeting, 2026 First A-Share and H-Share General Meetings

Livzon Pharmaceutical Group Inc.·May 29, 2026·16 pages

✨ AI Summary

The announcement details the resolutions passed during the 2025 Annual General Meeting and the first A-Share and H-Share meetings of 2026. Key decisions include the approval of the 2025 annual report, financial statements, and the appointment of auditors. No proposals were rejected, and all resolutions were passed with the required majority votes.

Summary generated by AI · Always verify with source document

Exchange Summary

AGM RESOLUTION

The Company held its Annual General Meeting of 2025 on 29 May 2026, during which the following proposal(s) was/were approved: 1. 2025 annual report and business performance report 2. 2025 work report of the board of directors 3. 2025 annual accounts report 4. 2025 profit distribution plan 5. Appointment of 2026 financial and internal control audit firm 6. Formulation of the remuneration management measures for directors 7. 2026 remuneration (allowance) plan for directors 8. 2026 application for comprehensive credit and estimated guarantee quota 9. Decrease of the Company's registered capital, adjustment of the board seats, amendments to the Company's articles of association, and handling the industrial and commercial registration amendment 10. General authorization to the board regarding the repurchase of H-shares 11. Election of non-independent directors, cumulative voting system applicable 11.1. Zhu Baoguo, non-executive director 11.2. Liu Daping, executive director 11.3. Tang Yanggang, executive director 11.4. Lin Nanqi, non-executive director 11.5. Qiu Qingfeng, non-executive director 12. Election of independent directors, cumulative voting system applicable 12.1. Luo Huiyuan, independent non-executive director 12.2. Cui Lijie, independent non-executive director 12.3. Wang Zhiyao, independent non-executive director 12.4. Kang Li, independent non-executive director The detailed profit distribution plan is as follows: 1) Cash dividend/10 shares (tax included): CNY14.30000000 2) Bonus issue from profit (share/10 shares): none 3) Bonus issue from capital reserve (share/10 shares): none

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· azure_openai

Special Reminder

The 2025 Annual General Meeting, the first A-Share General Meeting of 2026, and the first H-Share General Meeting of 2026 did not have any rejected proposals and did not involve changes to previously approved resolutions.

Meeting Convening and Attendance

(1) Meeting Sessions

The 2025 Annual General Meeting, the first A-Share General Meeting of 2026, and the first H-Share General Meeting of 2026 of Lijun Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company").

(2) Meeting Convener

The Board of Directors of the Company. The 34th meeting of the 11th Board of Directors was held on April 23, 2026, to review and approve the proposal to convene the 2025 Annual General Meeting, the first A-Share General Meeting of 2026, and the first H-Share General Meeting of 2026.

(3) Meeting Host

Mr. Tang Yanggang, Vice Chairman.

(4) Legality and Compliance of the Meeting

The convening of this shareholders' meeting complies with relevant laws, administrative regulations, departmental rules, normative documents, Shenzhen Stock Exchange business rules, and the Company's Articles of Association.

(5) Meeting Date and Time

Date and time of the on-site meeting: May 29, 2026 (Friday) at 14:00, sequentially holding the 2025 Annual General Meeting, the first A-Share General Meeting of 2026, and the first H-Share General Meeting of 2026.
Online voting time:
- (1) Internet voting system: May 29, 2026, from 9:15 to 15:00.
- (2) Trading system voting: May 29, 2026, during trading hours, i.e., 9:15-9:25, 9:30-11:30, and 13:00-15:00.

(6) Meeting Method

The shareholders' meeting was held using a combination of on-site voting and online voting.

(7) Share Registration Date

A-Share shareholders' registration date: May 22, 2026 (Friday).
H-Share shareholders' registration date: May 22, 2026 (Friday).

(8) Meeting Location

Conference Room, 6th Floor, Headquarters Building, Lijun Industrial Park, No. 38 Chuangye North Road, Jinwan District, Zhuhai City, Guangdong Province.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.